
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285a-6]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
                  subpart 1--national cancer institute
 
Sec. 285a-6. Breast and gynecological cancers


(a) Expansion and coordination of activities

    The Director of the Institute, in consultation with the National 
Cancer Advisory Board, shall expand, intensify, and coordinate the 
activities of the Institute with respect to research on breast cancer, 
ovarian cancer, and other cancers of the reproductive system of women.

(b) Coordination with other institutes

    The Director of the Institute shall coordinate the activities of the 
Director under subsection (a) of this section with similar activities 
conducted by other national research institutes and agencies of the 
National Institutes of Health to the extent that such Institutes \1\ and 
agencies have responsibilities that are related to breast cancer and 
other cancers of the reproductive system of women.
---------------------------------------------------------------------------
    \1\ So in original. Probably should not be capitalized.
---------------------------------------------------------------------------

(c) Programs for breast cancer

                           (1) In general

        In carrying out subsection (a) of this section, the Director of 
    the Institute shall conduct or support research to expand the 
    understanding of the cause of, and to find a cure for, breast 
    cancer. Activities under such subsection shall provide for an 
    expansion and intensification of the conduct and support of--
            (A) basic research concerning the etiology and causes of 
        breast cancer;
            (B) clinical research and related activities concerning the 
        causes, prevention, detection and treatment of breast cancer;
            (C) control programs with respect to breast cancer in 
        accordance with section 285a-1 of this title, including 
        community-based programs designed to assist women who are 
        members of medically underserved populations, low-income 
        populations, or minority groups;
            (D) information and education programs with respect to 
        breast cancer in accordance with section 285a-2 of this title; 
        and
            (E) research and demonstration centers with respect to 
        breast cancer in accordance with section 285a-3 of this title, 
        including the development and operation of centers for breast 
        cancer research to bring together basic and clinical, biomedical 
        and behavioral scientists to conduct basic, clinical, 
        epidemiological, psychosocial, prevention and treatment research 
        and related activities on breast cancer.

    Not less than six centers shall be operated under subparagraph (E). 
    Activities of such centers should include supporting new and 
    innovative research and training programs for new researchers. Such 
    centers shall give priority to expediting the transfer of research 
    advances to clinical applications.

               (2) Implementation of plan for programs

        (A) The Director of the Institute shall ensure that the research 
    programs described in paragraph (1) are implemented in accordance 
    with a plan for the programs. Such plan shall include comments and 
    recommendations that the Director of the Institute considers 
    appropriate, with due consideration provided to the professional 
    judgment needs of the Institute as expressed in the annual budget 
    estimate prepared in accordance with section 285a-2(9) \2\ of this 
    title. The Director of the Institute, in consultation with the 
    National Cancer Advisory Board, shall periodically review and revise 
    such plan.
---------------------------------------------------------------------------
    \2\ So in original. Probably should be section ``285a-2(b)(9)''.
---------------------------------------------------------------------------
        (B) Not later than October 1, 1993, the Director of the 
    Institute shall submit a copy of the plan to the President's Cancer 
    Panel, the Secretary and the Director of NIH.
        (C) The Director of the Institute shall submit any revisions of 
    the plan to the President's Cancer Panel, the Secretary, and the 
    Director of NIH.
        (D) The Secretary shall provide a copy of the plan submitted 
    under subparagraph (A), and any revisions submitted under 
    subparagraph (C), to the Committee on Energy and Commerce of the 
    House of Representatives and the Committee on Labor and Human 
    Resources of the Senate.

(d) Other cancers

    In carrying out subsection (a) of this section, the Director of the 
Institute shall conduct or support research on ovarian cancer and other 
cancers of the reproductive system of women. Activities under such 
subsection shall provide for the conduct and support of--
        (1) basic research concerning the etiology and causes of ovarian 
    cancer and other cancers of the reproductive system of women;
        (2) clinical research and related activities into the causes, 
    prevention, detection and treatment of ovarian cancer and other 
    cancers of the reproductive system of women;
        (3) control programs with respect to ovarian cancer and other 
    cancers of the reproductive system of women in accordance with 
    section 285a-1 of this title;
        (4) information and education programs with respect to ovarian 
    cancer and other cancers of the reproductive system of women in 
    accordance with section 285a-2 of this title; and
        (5) research and demonstration centers with respect to ovarian 
    cancer and cancers of the reproductive system in accordance with 
    section 285a-3 of this title.

(e) Report

    The Director of the Institute shall prepare, for inclusion in the 
biennial report submitted under section 284b of this title, a report 
that describes the activities of the National Cancer Institute under the 
research programs referred to in subsection (a) of this section, that 
shall include--
        (1) a description of the research plan with respect to breast 
    cancer prepared under subsection (c) of this section;
        (2) an assessment of the development, revision, and 
    implementation of such plan;
        (3) a description and evaluation of the progress made, during 
    the period for which such report is prepared, in the research 
    programs on breast cancer and cancers of the reproductive system of 
    women;
        (4) a summary and analysis of expenditures made, during the 
    period for which such report is made, for activities with respect to 
    breast cancer and cancers of the reproductive system of women 
    conducted and supported by the National Institutes of Health; and
        (5) such comments and recommendations as the Director considers 
    appropriate.

(July 1, 1944, ch. 373, title IV, Sec. 417, as added Pub. L. 103-43, 
title IV, Sec. 401, June 10, 1993, 107 Stat. 153.)

                         Change of Name

    Committee on Energy and Commerce of House of Representatives treated 
as referring to Committee on Commerce of House of Representatives by 
section 1(a) of Pub. L. 104-14, set out as a note preceding section 21 
of Title 2, The Congress.

                  Section Referred to in Other Sections

    This section is referred to in section 285a-8 of this title.
